ArticleFrontiers in pharmacology2021

Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment.

Shihui Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.